Strengthen your UPSC exam preparation with daily IAS and UPSC current affairs

Recent Developments:

• NITI Aayog has released the "Strategic Roadmap for Making Ayurveda Global", outlining a phased strategy from 2025 to 2047 to expand Ayurveda's global footprint.
• The roadmap analyses the reasons behind the stronger global presence of Traditional Chinese Medicine (TCM) compared to Ayurveda and proposes institutional, regulatory and scientific reforms to bridge this gap.
• The strategy seeks to transform Ayurveda from a largely domestic traditional healthcare system into an internationally recognised, evidence-based and globally integrated medical system.

Current Global Status of Ayurveda:

Global Expansion and Recognition:

• Exports of Ayurveda and herbal products increased from USD 1.09 billion (2014) to USD 2.16 billion (2023), with products reaching nearly 150 countries.
• Ayurveda has received formal recognition in nearly 30 countries through licensing arrangements, academic partnerships and regulatory mechanisms.
• Ayurveda research activities are now being conducted across nearly 70 countries, reflecting increasing international scientific interest.

Human Resources and Academic Presence:

• India possesses a strong domestic ecosystem with over 355,000 trained Ayurveda practitioners.
• Nearly 95% of qualified practitioners continue to practice within India, limiting Ayurveda's international availability.
• Ayush Chairs established in foreign universities promote Ayurveda education, research and academic collaboration, although a globally standardised curriculum is yet to be developed.

Global Institutional Recognition:

• The WHO Global Traditional Medicine Centre (GTMC) established at Jamnagar, Gujarat, has strengthened international cooperation in traditional medicine.
• The World Health Organization (WHO) has incorporated Ayurveda, Siddha and Unani (ASU) into the International Classification of Diseases (ICD-11) through the supplementary Traditional Medicine Conditions (TM-2) module.
• WHO has also initiated coding of ASU interventions under the International Classification of Health Interventions (ICHI) to facilitate global documentation, research, billing and health system integration.

SWOT Analysis of Ayurveda Globalisation:

Strengths:

• Ayurveda emphasises preventive healthcare, holistic wellness and personalised treatment, aligning with evolving global healthcare priorities.
• The Prakriti-based approach provides individualised healthcare based on constitutional characteristics.
• More than 5,000 years of traditional knowledge and the worldwide acceptance of Yoga enhance Ayurveda's cultural credibility.
• Ayurveda complements modern medicine, particularly in preventive healthcare, chronic disease management, rehabilitation and lifestyle disorders.

Weaknesses:

• Ayurveda lacks uniform legal recognition as a medical system across many countries.
• Absence of internationally standardised education, licensing and regulatory mechanisms restricts professional mobility.
• Personalised treatment approaches make large-scale Randomized Controlled Trials (RCTs) comparatively difficult.
• Variations in manufacturing quality, regulatory compliance, certification standards and insurance coverage reduce international acceptance.

Opportunities:

• Ayush Chairs, Ayush Scholarships and the Ayush Visa can significantly expand global outreach.
• Greater collaboration with the WHO Global Traditional Medicine Centre (GTMC) and wider adoption of ICHI coding can strengthen global integration.
• Expansion of the USD 1 trillion global wellness market, rising demand for nutraceuticals, preventive healthcare and Medical Value Travel (MVT) provides significant growth opportunities.
• Stronger scientific validation and international collaborative research can improve global credibility and market acceptance.

Threats:

• Weak coordination among researchers, practitioners, industry, academic institutions and regulators slows international expansion.
• Many Ayurvedic products continue to be marketed internationally as dietary supplements instead of regulated medicines.
• Rapid global expansion of Traditional Chinese Medicine (TCM) supported by strong governmental investment intensifies competition.
• Balancing classical Ayurvedic principles with evolving international scientific and regulatory standards remains a continuing challenge.

Ayurveda and Traditional Chinese Medicine: Comparative Assessment

Global Practitioner Base:

• Traditional Chinese Medicine (TCM) has over 34,000 licensed acupuncturists in the United States alone and is regulated across 47 US states.
• Ayurveda currently has nearly 5,000 practitioners outside India, with international practice largely supported by the Indian diaspora.

Global Market and Manufacturing:

• Traditional Chinese Medicine (TCM) exports are valued at approximately USD 5.4 billion, supported by overseas WHO-GMP/GMP manufacturing facilities.
• Ayurveda exports reached USD 2.16 billion (2023), while manufacturing remains predominantly concentrated within India.

International Institutional Presence:

• Traditional Chinese Medicine (TCM) operates through more than 30 overseas centres, supported by the Belt and Road Initiative (BRI).
• Ayurveda expands internationally through the WHO Global Traditional Medicine Centre (GTMC) and Ayush Information Cells established in partner countries.

Insurance Coverage:

• Traditional Chinese Medicine (TCM) receives insurance support under Medicare in the United States and several other countries including Japan and Germany.
• Ayurveda currently enjoys substantial insurance support mainly within India, while international insurance coverage remains limited.

Standardisation Framework:

• Traditional Chinese Medicine (TCM) benefits from a dedicated ISO Technical Committee for international standard development.
• Ayurveda presently lacks a dedicated international ISO Technical Committee.

NITI Aayog's Strategic Roadmap:

Short-Term Strategy (Up to 2029): Building the Foundation

• Establish a high-level Mission Steering Group (MSG) chaired by the Minister of Ayush to coordinate research, education, trade and international cooperation.
• Develop a Global Ayurveda Register (GAR) aligned with WHO standards for practitioner credentialing and Continuous Professional Development (CPD) under the National Commission for Indian System of Medicine (NCISM).
• Create a comprehensive Global Information Portal providing country-specific information on licensing, visas and regulatory requirements.
• Accelerate certification of manufacturers according to WHO-GMP-equivalent standards and publish a public database of certified facilities.
• Develop an export-oriented Ayurvedic Pharmacopoeia supported by Good Agricultural and Collection Practices (GACP) and contaminant profiling.
• Establish a real-time Ayurveda Trade Dashboard while aligning products with appropriate Harmonized System (HS) Codes to maximise benefits under Free Trade Agreements (FTAs).

Medium-Term Strategy (Up to 2035): Market Integration

• Secure product registrations under international regulatory frameworks such as the European Union Traditional Herbal Medicinal Products Directive (THMPD).
• Introduce pilot insurance coverage for Ayurveda in selected Organisation for Economic Co-operation and Development (OECD) countries.
• Promote international professional mobility through Mutual Recognition Arrangements (MRAs) with countries and regional groupings including G20, BRICS and ASEAN.
• Introduce Ayurveda electives and micro-credential programmes in foreign medical institutions through the Ayush Chair initiative.
• Develop international Medical Value Travel (MVT) hubs beginning with Mauritius, supported by integrated Ayush Visa packages.
• Expand multinational clinical research through WHO Collaborating Centres while strengthening the Traditional Knowledge Digital Library (TKDL) for intellectual property protection.

Long-Term Strategy (Up to 2047): Systemic Global Integration

• Achieve formal recognition of Ayurveda within at least 20 national healthcare systems.
• Secure insurance coverage for selected Ayurveda treatments in at least 10 countries, particularly for chronic diseases, musculoskeletal disorders, metabolic conditions, stress-related disorders and women's health.
• Establish a worldwide network of International Ayurveda Centres of Excellence integrating clinical services, education, laboratory facilities and research.
• Develop Ayurveda as a globally trusted, scientifically validated healthcare brand supported by robust evidence.

Significance of the Roadmap:

Healthcare Significance:

• Greater international acceptance can strengthen preventive healthcare and integrative medicine.
• Scientific validation can improve confidence among healthcare professionals and policymakers.
• Expanded research collaboration can enhance evidence-based traditional medicine.

Economic and Strategic Significance:

• Expansion of Ayurveda can generate employment, exports and investment in the healthcare sector.
• Greater international acceptance can strengthen India's cultural diplomacy and soft power.
• Medical tourism and wellness services can contribute significantly to economic growth.

Challenges Ahead:

Implementation Challenges:

• Uniform international regulatory recognition remains a major policy challenge.
• Large-scale clinical evidence consistent with global scientific standards needs further expansion.
• Manufacturing quality and regulatory compliance require continuous strengthening.
• International insurance integration and professional mobility will depend upon sustained diplomatic engagement.

Conclusion:

• The Strategic Roadmap for Making Ayurveda Global provides a comprehensive framework for transforming Ayurveda into a globally recognised healthcare system by combining traditional knowledge with scientific validation, regulatory harmonisation and international institutional cooperation.
• Successful implementation can strengthen India's healthcare diplomacy, expand global acceptance of traditional medicine and position Ayurveda as an important pillar of global integrative healthcare by 2047.

Value Addition for UPSC:

Important Concepts:

• Ayurveda: Traditional Indian system of medicine based on preventive healthcare, holistic wellness and individualised treatment.
• Prakriti: Individual constitutional profile forming the basis of personalised diagnosis and treatment in Ayurveda.
• Medical Value Travel (MVT): Cross-border travel undertaken to obtain healthcare, wellness and medical treatment services.
• Integrative Medicine: Healthcare approach combining evidence-based modern medicine with scientifically validated traditional medical systems.
• Evidence-Based Medicine: Clinical decision-making supported by systematic scientific research and validated medical evidence.

Important Institutions and Initiatives:

• NITI Aayog: Apex public policy institution responsible for long-term strategic planning and policy recommendations.
• World Health Organization (WHO) Global Traditional Medicine Centre (GTMC): International centre established at Jamnagar, Gujarat, to strengthen research and global cooperation in traditional medicine.
• National Commission for Indian System of Medicine (NCISM): Statutory regulatory body responsible for education and professional standards in Indian systems of medicine.
• Traditional Knowledge Digital Library (TKDL): Digital repository documenting India's traditional medicinal knowledge to prevent biopiracy and protect intellectual property.
• Ayush Visa: Special visa initiative facilitating international access to treatment under India's traditional systems of medicine